U-Blot® Research Grade UliledlimabCat. No. WA3724Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade UliledlimabCat. No. WA3724
U-Blot® Research Grade UlenistamabCat. No. WA3723
U-Blot® Research Grade UcenprubartCat. No. WA3722
U-Blot® Research Grade UblituximabCat. No. WA3721
U-Blot® Research Grade ubletamigCat. No. WA3720
U-Blot® Research Grade UbamatamabCat. No. WA3719
U-Blot® Research Grade TuvonralimabCat. No. WA3718
U-Blot® Research Grade TuvirumabCat. No. WA3717
U-Blot® Research Grade TusamitamabCat. No. WA3716
U-Blot® Research Grade turmetabartCat. No. WA3715
U-Blot® Research Grade turigrobartCat. No. WA3714
U-Blot® Research Grade turenkibartCat. No. WA3713